ArticleBMJ open2020

Risk of infections and cardiovascular and venous thromboembolic events associated with JAK inhibitors in rheumatoid arthritis: protocols of two systematic reviews and network meta-analyses.

Carlos Alves et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.